Candida krusei fungemia in an unrelated allogeneic hematopoietic stem cell transplant patient successfully treated with Caspofungin [3]

Bone Marrow Transplantation

Volumn 35, Issue 12, 2005, Pages 1215-1216

  Fanci, R ^a   Guidi, S ^a   Bonolis, M ^a   Bosi, A ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; FLUCONAZOLE; FLUCYTOSINE; FOSCARNET; GANCICLOVIR; HLA ANTIGEN; IMIPENEM; ITRACONAZOLE; VANCOMYCIN; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BLOOD CULTURE; CANDIDA KRUSEI; CASE REPORT; CENTRAL VENOUS CATHETER; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEVICE REMOVAL; ESCHERICHIA COLI; FEVER; FUNGEMIA; FUNGUS CULTURE; GRAFT INFECTION; HLA MATCHING; HUMAN; IN VITRO STUDY; INTRAVENOUS CATHETER; LETTER; LUNG INFILTRATE; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SIBLING; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VASCULAR ACCESS;

ADULT; CANDIDIASIS; FUNGEMIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; LEUKEMIA, MONOCYTIC, ACUTE; MALE; OPPORTUNISTIC INFECTIONS; PEPTIDES, CYCLIC; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 21244435974     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704976     Document Type: Letter

References (7)

1. Segal BH, Bow EJ, Menichetti F. Fungal infections in nontransplant patients with hematologic malignancies. Infect Dis Clin North Am 2002; 16: 935-964.
2. Krcmery V, Krupova I, Denning DW. Invasive yeast infections other than Candida spp. in acute leukaemia. J Hosp Infect 1999; 41: 181-194.
3. Canuto MM, Rodero FG. Antifungal drug resistance to azoles and polyenes. Lancet Infect Dis 2002; 9: 550-563.
4. Ullmann AJ. Review of the safety, tolerability and drug interactions of the new antifungal agents caspofungin and voriconazole. Curr Med Res Opin 2003; 19: 263-271.
5. Onishi J, Meinz M, Thompson J et al. Discovery of novel antifungal 1,3-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother 2000; 44: 368-377.
6. Bachman SP, Patterson TF, Lopez-Rilot JL. In vitro activity of caspofungin (MK -0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance. J Clin Microbiol 2002; 40: 2228-2230.
7. McGee WT, Tereso GJ. Successful treatment of Candida krusei infection with caspofungin acetate, a new antifungal agent. Crit Care Med 2003; 31: 1577-1578.